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Abstract One of the most powerful strategies to
investigate biology we have as scientists, is the ability
to transfer genetic material in a controlled and
deliberate manner between organisms. When applied
to livestock, applications worthy of commercial
venture can be devised. Although initial methods used
to generate transgenic livestock resulted in random
transgene insertion, the development of SCNT tech-
nology enabled homologous recombination gene tar-
geting strategies to be used in livestock. Much has
been accomplished using this approach. However,
nowwe have the ability to change a specific base in the
genome without leaving any other DNAmark, with no
need for a transgene. With the advent of the genome
editors this is now possible and like other significant
technological leaps, the result is an even greater
diversity of possible applications. Indeed, in merely
5 years, these ‘molecular scissors’ have enabled the
production of more than 300 differently edited pigs,
cattle, sheep and goats. The advent of genome editors
has brought genetic engineering of livestock to a
position where industry, the public and politicians are
all eager to see real use of genetically engineered
livestock to address societal needs. Since the first
transgenic livestock reported just over three decades
ago the field of livestock biotechnology has come a
long way—but the most exciting period is just starting.
Keywords Gene targeting  Genome editing 
Livestock  TALENs  CRISPR/Cas9  SCNT or
cloning  Cytoplasmic injection
Introduction
Biology has many facets and our ability to utilize
novel biological pathways increases every year. As
scientists we strive to develop tools and strategies to
help us tease apart biological process so we can better
understand them. To achieve this understanding,
biologists often turn to the powerful approach involv-
ing gene transfer enabling the consequence of alter-
ations in gene activity to be studied in vivo. Since the
first steps in the early 1970s involving the transfor-
mation of bacteria, the successful transfer of genes
into first mammals and then plants quickly followed,
with similar progress in fish and insects soon achieved.
The first transgenic livestock announced in the mid-
1980s (Hammer et al. 1985) followed the pioneering
work of Palmiter and Brinster in mice (Brinster et al.
1981). Since then we have come a long way, with an
explosion of activity in recent years.
The field of genetically engineered livestock has
been driven by technological advances. This 30 year
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journey started slowly, with pronuclear injection
(PNI) being the first tool in the kit (Hammer et al.
1985). Although conceptually simple—delivering
DNA by injection through a fine glass needle into
one of the pronuclei of a fertilised egg—this method is
technically demanding and those who could success-
fully accomplish it were given great respect by the
research community. PNI was king for the first decade
of transgenic livestock research, with the commercial
enterprises emerging on the back of this technique
focused on producing human biomedical proteins in
animal bioreactors (Ja¨nne and Alhonen 1998; Kind
and Schnieke 2008). But it has limitations. Efficiency
of generating founder animals was low, and the
injected DNA construct integrated randomly into the
genome resulting in unpredictable transgene expres-
sion profiles. The field needed to progress.
Just over 10 years ago, oncoretroviruses were first
employed to produce transgenic livestock (Chan et al.
1998; Cabot et al. 2001). While harnessing the innate
ability of these replication defective viral vectors to
transduce the livestock zygote dramatically increased
the efficiency with which founder transgenic animals
could be created, it quickly became obvious that there
were issues with silencing of transgene expression in
subsequent generations. The move from oncoretro-
viruses such as MoMLV to lentiviruses increased the
transgenesis efficiencies further; Whitelaw et al.
(2004) used an EIAV-based virus encoding eGFP to
produce 40 founder piglets, 37 of which were trans-
genic and 35 of which expressed eGFP. Breeding from
a subset of these for four generations revealed no loss
of gene expression as assessed by visual GFP fluores-
cence and western blot for GFP protein (Whitelaw
et al. unpublished data), in contrast to other studies
with lentivirus transgenes where gene silencing was
observed as assessed by loss of GFP fluorescence and
DNA methylation (Hofmann et al. 2006). This
impressive efficiency has allowed lentiviruses to be
used to create a cohort of transgenic founder animals
to model human disease (Kostic et al. 2013). However,
viral vectors remain limited to a small cargo carrying
capacity (around 8 Kb for lentiviruses) and the fact
that they can only act as unidirectional delivery
vehicles. Offering comparable efficiencies, trans-
poson-based transgenesis (Carlson et al. 2011; Jakob-
sen et al. 2011) is less constrained with regard to
vector design and the vagaries of transgene silencing
(Ivics et al. 2014).
Gene targeting by homologous recombination
Those working on transgenic livestock looked around
to see what was being achieved in other mammalian
species. In particular attention was drawn to what was
technically possible in rodent research, where in
addition to random transgene integration through
pronuclear injection, the ability to perform gene
targeting was possible. Gene targeting is made possi-
ble through homologous recombination (HR) which
involves the exchange of nucleotides between two
similar or identical DNA sequences (Capecchi 1989).
In this way a gene can be targeted for disruption,
termed knockout (KO), or used as a docking site for
transgene insertion, termed knock in (KI)—this
achievement attracted the first of two Nobel Prizes in
this field.
HR in mammalian cells is an inefficient process, so
relied on inclusion of a selectable marker in the
construct to enable only the cells containing gene
targeted events to survive. Subsequently more elegant
strategies involving recombination-steps, driven for
example by Cre recombinase (Nagy et al. 2009),
enabled removal of the undesired marker gene. The
latter has also enabled targeting of a transgene to a
given genetic ‘harbour’, usually intended as a site
permissive for expression of the transgene (Bronson
et al. 1996; Wallace et al. 2000). The multiple steps
involved and the low targeting efficiencies achieved
meant that HR was not practical in zygotes; a cell-
based system was required and the mouse research
community had a very good one. Embryonic stem
cells (ESCs), derived from the preimplantation
embryo, have the ability to both self-renew and retain
pluripotential characteristics (Torres-Padilla and
Chambers 2014; Martello and Smith 2014). The first
property facilitates the lengthy process of gene
targeting while the latter allows the engineered cell
to contribute to the germline after transfer into the
early embryo (Capecchi 1989).
HR and ESCs transformed mouse-based research in
the 1980s and until recently formed the mainstay for
this research community, enabling the development of
huge and important research resources. The race was
on to achieve similar progress in livestock. But there
was a hurdle. Livestock ESCs had not and still have
not been isolated (Malaver-Ortega et al. 2012). For
reasons that remain a mystery no robust livestock
ESCs have ever been demonstrated, even though huge
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advances in our understanding of both rodent and
human ESC biology (Torres-Padilla and Chambers
2014) and the requirements for their maintenance in
culture has been achieved (Buehr et al. 2008). An
alternative method of producing ESC-like cells
through a process involving regression of differenti-
ated cells was developed in 2006 (Takahashi and
Yamanaka 2006). These induced pluripotent stem
cells (iPSC) can self-renew and like ESCs can
differentiate into many different cells types including
the germline but are not derived from the early
embryo. Again this development was pioneered in
mice—winning the second Nobel Prize in the field—
and was quickly transferred into human biology.
However, while there have been some limited suc-
cesses in livestock, iPSCs remain surprisingly difficult
to isolate and even harder to maintain (Telugu et al.
2011; Ezashi et al. 2012; Nowak-Imialek and Nie-
mann 2012).
Cloning first enabled gene targeting in livestock
Since robust pluripotent livestock cells have to-date
proven beyond reach, the livestock research commu-
nity had to come up with an alternative—which they
did in the mid-1990s. That alternative manifested in
the birth of Dolly the sheep (Wilmut et al. 1997). Next
year will be the 20th anniversary of Dolly and in these
intervening years considerable use of somatic cell
nuclear transfer (SCNT), more commonly referred to
as cloning, has been the method of choice for many
teams engaged with producing transgenic livestock
(Kues and Niemann 2011; Prather 2013; Wolf et al.
2014). SCNT utilises primary cells grown in culture.
During this in vitro phase manipulation of the donor
genome utilising methodologies based on HR can be
applied, with the selected transgenic cell then used to
reconstitute an enucleated oocyte. The resulting
transgenic animals are clones, derived from geneti-
cally identical parental cells. SCNT has enabled
transgenic livestock research to develop since the late
1990s. Nevertheless, even with technical advances to
simplify the technique such as handmade cloning
(Peura and Vajta 2003), SCNT remains technically
difficult and only a few labs around the world have
truly mastered it.
By the turn of the millennium we were able to do
gene addition, gene KO and gene KI—the latter two
only by SCNT—in livestock. Given the cost involved
in these studies, the need for SCNT and the complexity
of HR driven gene targeting, transgenic livestock
research has focussed primarily on biomedical appli-
cations. Here notable progress has been made in the
extent of resources now available for xenotransplan-
tation applications (Klymiuk et al. 2010; Satyananda
et al. 2013; Cooper et al. 2014) and the commercial
success of animal bioreactor derived products (Bo¨sze
et al. 2008). Agricultural applications, however, have
lagged behind primarily due to concerns over public
acceptance of livestock containing transgenes in the
food chain.
The revolution that is genome editors
1996 was a watershed year for the generation of
engineered animals; not only did it include the birth of
Dolly but also the generation of the first programmable
nuclease (Kim et al. 1996). The former was trumpeted
loudly by the media with reverberations still echoing
around this field. It was over a decade for the latter to
emerge as the technical revolution it is. Nearly
20 years on we now have a variety of tools and
techniques at our disposal for the generation of
engineered livestock species. Until recently we have
only been able to dream of the ability to change a
specific base in the genome without leaving any other
DNA footprint; or the ability to induce precise
insertions or deletions easily and efficiently in the
germline of livestock. With the advent of the genome
editors this is now possible.
Designer nucleases are used to generate a double
strand break (DSB) at a desired genomic locus and can
be divided into two broad categories; synthetic and
natural. The first category includes the original zinc
finger nuclease (ZFN; Kim et al. 1996) and the newer
transcription activator like effector nuclease (TALEN;
Christian et al. 2010) both of which are modular
proteins containing an adaptable DNA binding domain
fused to the nuclease domain of FokI. In the case of
ZFNs each individual zinc finger binds three DNA
bases whereas each TAL repeat binds a single base.
Both ZFNs and TALENs are employed as pairs which
recognise opposing DNA strands and orientate such
that their fused FokI monomers are brought together
on the intervening sequence to form an active enzyme
dimer that cleaves both strands. In a refinement of this
Transgenic Res
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system the FokI monomers have been mutated such
that heterodimerisation is obligate for FokI cutting
(Miller et al. 2007; Doyon et al. 2011).
The second category includes meganucleases
(Smith et al. 2006) and the newest, and currently the
most popular of the designer nucleases, the clustered
regularly interspaced short palindromic repeat/
CRISPR associated gene (CRISPR/Cas) system (Cong
et al. 2013; Mali et al. 2013; Jinek et al. 2013). Uptake
of meganucleases by the livestock research commu-
nity has not been widespread, presumably due to the
laborious protein re-design and optimisation that is
required to repurpose these molecules to a novel DNA
sequence (Smith et al. 2006), however, effort to
develop this nuclease tool continues (Me´noret et al.
2013). In contrast, the CRISPR/Cas system, which was
first described just over 2 years ago, has seen an
unprecedented exponential increase in its use (Serug-
gia and Montoliu 2014). This relatively simple system
is adapted from an innate immune mechanism com-
mon to many bacteria and archaea, the function of
which is to protect against invading viruses. The most
widely used system at present is based on the CRISPR/
Cas9 of Streptococcus pyogenes and involves a short
guide RNA (sgRNA) sequence complexed with Cas9
nuclease. Specificity is determined by hybridisation
between the 20 ribonucleotides of the complexed
Cas9/guide and the nascent DNA target sequence,
further restricted to sites immediately proximal to a
protospacer adjacent motif (PAM) sequence (Cong
et al. 2013; Mali et al. 2013; Jinek et al. 2013).
Following generation of a DSB at the desired locus,
repair can occur in one of two ways; non-homologous
end joining (NHEJ) or homology dependent repair
(HDR; Fig. 1). In most cases of DSBs are repaired by
NHEJ, with the two ends of the break being brought
together and ligated. As a consequence of endogenous
nuclease activity at the cut site this process is error
prone and often results in the introduction small
insertions/deletions (indels) at the repair site (Kanaar
et al. 1998). Alternatively, if a repair template is
provided in trans, evoking HDR in addition to NHEJ,
the introduction of desired changes to the sequence at
the targeted locus can be achieved (Kanaar et al.
1998). Deletion of regions of the genome can be
achieved by generating of a pair of DSBs flanking the
region to be deleted and their subsequent repair by
NHEJ (Carlson et al. 2012; He et al. 2015b;Whitworth
et al. 2014; Fig. 2).
Nickases are modified nucleases that only cut one
strand of DNA, and mutagenesis of both FokI and
Cas9 has resulted in nickase versions of these
enzymes. By designing reagents such that staggered
nicks are created at the target site (e.g. 2 pairs of
ZFNickases), a DSB still occurs (Kim et al. 2012) and
is repaired by either NHEJ or HDR. One potential
advantage of this approach is that binding at off-target
sites results in a nick rather than a DSB, with
subsequent repair by the break excision repair (BER)
pathway which leaves no mark on the genome. It is too
early to know how useful the nickases strategy will be
given the reduced efficiency associated with this Cas9
variant but the theoretical promise of reduced off-
targets seems to be real (Ren et al. 2014; Frock et al.
2015).
So much achieved in such a short period of time
In the last 5 years, genome editors have been used to
mediate the generation of more than 300 edited pigs,
cattle, sheep and goats (Table 1). These animals can
potentially serve as organ donors (Hauschild et al.
2011; Li et al. 2015), disease models (Tan et al. 2013),
bioreactors (Liu et al. 2013) or founder animals of
genetic lines with enhanced productivity (Proudfoot
et al. 2015) or disease resistance traits (Lillico et al.
2013;Wu et al. 2015). To achieve this, our community
NHEJHDR 
LIVESTOCK
Fig. 1 Routes to genome edited livestock. Designer nucleases
have been successfully used to modify both zygotes and somatic
cells. Modification and selection of fibroblasts coupled with
SCNT has resulted in the generation of HDR and NHEJ edited
livestock. NHEJ edited animals have been produced via zygote
CPI whereas, to date, HDR edited animals have not been
reported from edited zygotes
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Table 1 A list of published pigs, cattle, sheep and goats ever generated by genome editors
Gene(s)* Editor Route Genotypes** E.T./R/P*** Live/total
born
F0
edited/
live
References
NHEJ
Pig
PPARc ZFN SCNT ± 1340/8/4 10/10 2/10 Yang et al. (2011)
a 1,3GT ZFN SCNT ±, -/- 272/3/2 2/2 2/2 Hauschild et al. (2011)
eGFP ZFN SCNT -/- 315/2/2 7/7 6/7 Whyte et al. (2011)
LDLR TALEN SCNT -/- n.a./9/7 18/22 18/18 Carlson et al. (2012)
a 1,3GT ZFN SCNT ±, -/- 304/3/2 3/4 3/3 Li et al. (2013)
RELA ZFN CPI -/- 109/3/2 9/9 1/9 Lillico et al. (2013)
RELA TALEN CPI ±, ±/-, =/- 393/11/6 41/46 5/41 Lillico et al. (2013)
CMAH ZFN SCNT ± 431/2/2 11/13 11/11 Kwon et al. (2013)
IL2RG ZFN SCNT -/Y 199/2/2 4/4a 4/4 Watanabe et al. (2013)
a 1,3GT CMAH ZFN SCNT -, -/-, - 477/4/1 4/5 4/4 Lutz et al. (2013)
DAZL TALEN SCNT -/- n.a./3/2 3/5c 3/3 Tan et al. (2013)
a 1,3GT TALEN SCNT -/- 1919/7/2 3/4 3/3 Xin et al. (2013)
a 1,3GT ZFN SCNT -/- 2093/11/8 15/15 3/15 Bao et al. (2014)
RAG1 TALEN SCNT -/- 1285/9/6 12/24 9/12 Huang et al. (2014)
RAG2 TALEN SCNT ±, -/- 3633/15/7 15/18 13/15 Huang et al. (2014)
RAG2 TALEN SCNT ±, -/- 1903/9/9 22/31 13/13d Lee et al. (2014)
GHR TALEN HMC -/- 654e/6/n.a. 10/12 7/10 Li et al. (2014)
DJ-1 TALEN SCNT ±, -/- 687/5/1 3/4 3/3 Yao et al. (2014)
vWF CRISPR/Cas9 CPI ±/- , =/- 76/5/3 16/16 11/16 Hai et al. (2014)
SLA-1,2,3 CRISPR/Cas9 SCNT -, -, -/- ,-, -, - 265/2/2b 3/3 3/3 Reyes et al. (2014)
CD163 CRISPR/Cas9 SCNT -/- 2734/13/8 37/39 34/37 Whitworth et al. (2014)
CD1d CRISPR/Cas9 SCNT -/- 1055/5/4 13/13 12/13 Whitworth et al. (2014)
CD163 CRISPR/Cas9 CPI -/- 96e/2/1 4/4 4/4 Whitworth et al. (2014)
CD1d CRISPR/Cas9 CPI -/-, =/- 110e/2/1 4/4 4/4 Whitworth et al. (2014)
TYR CRISPR/Cas9 SCNT -/- 1705/7/4 18/18 15/18 Zhou et al. (2014)
PARK2, PINK1 CRISPR/Cas9 SCNT -, -/-, - 1729/10/4 18/20 18/18 Zhou et al. (2014)
IgM CRISPR/Cas9 SCNT -/- 500e/5/2 3/5 3/3 Chen et al. (2015)
PKD1 ZFN SCNT ± 4987/13/5 20/25 13/20 He et al. (2015a)
a 1,3GT, CMAH
iGb3S
CRISPR/Cas9 SCNT -, -, -/-, -, - 179/2/2 10/12 5/10f Li et al. (2015)
Npc1l1 CRISPR/Cas9 CPI =/- 105/4/2 12/12 12/12 Wang et al. (2015)
Cattle
BLG ZFN SCNT -/- 995e/119/50 8/8 8/8 Yu et al. (2011)
GDF8 ZFN SCNT -/- 1336e/123/35 n.a./18 2/n.a. Luo et al. (2014)
GDF8 TALEN CPI ±/- 20e/11/2 2/4  Proudfoot et al. (2015)
Sheep
GDF8 CRISPR/Cas9 CPI ±/- 213/55/31 35/35 2/35 Han et al. (2014)
GDF8 TALEN CPI ± 26e/9/8 12/12 1/12 Proudfoot et al. (2015)
Goat
GDF8 CRISPR/Cas9 SCNT -/- 269/21/7 3/3 3/3 Ni et al. (2014)
HDR
Pig
CMAH ZFN SCNT -/Neo 1619/7/4 7/7 5/7 Kwon et al. (2013)
DAZL TALEN SCNT -/in4 n.a./3/2 2/3 2/2 Tan et al. (2013)
APC TALEN SCNT in4/in4 n.a./3/2 5/6 5/5 Tan et al. (2013)
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has been progressively expanding the livestock
genome engineering toolbox to include state-of-the-
art technologies, first ZFNs (Yang et al. 2011; Whyte
et al. 2011), then TALENs (Carlson et al. 2012) and
CRISPR/Cas9 (Hai et al. 2014; Fig. 3).
The creation of the first genome edited animals
relied on the modification of primary cells which were
then used as nuclear donors for embryo reconstruction
in SCNT (Hauschild et al. 2011; Carlson et al. 2012;
Fig. 3). An efficient alternative, direct modification of
zygotes by cytoplasmic injection (CPI) of the editors,
soon followed (Fig. 4a; Lillico et al. 2013; Hai et al.
2014) rekindling the microinjection skills used for the
first transgenic livestock (Fig. 3). Adding to these
initial reports that described NHEJ events, the ability
to introduce defined sequences into a targeted locus
through HDR, using either single strand DNA
oligonucleotides (ssODN; Tan et al. 2013) or plasmids
as repair templates (Liu et al. 2013;Wu et al. 2015) has
been demonstrated for livestock. Rather than depend-
ing on random changes at the target site introduced by
the error prone NHEJ repair pathway, these defined
Table 1 continued
Gene(s)* Editor Route Genotypes** E.T./R/P*** Live/total
born
F0
edited/
live
References
Cattle
CSN2 ZFN or ZFNickase SCNT ?/lst 1671e/559/140 14/19 14/14 Liu et al. (2013)
CSN2 ZFN SCNT ?/hLYZ 236e/118/20 5/5 5/5 Liu et al. (2014)
MAT1A-SFTPA1 g TALENickase SCNT ?/SP110 465e/147/50 23/23 13/13 Wu et al. (2015)
Goat
BLG TALEN SCNT -/hLFg n.a. 5/n.a. 2/5 Cui et al. (2015)
Publications were collected by searching the databases of Google Scholar and PubMed with keywords ‘‘ZFN’’ or ‘‘zinc finger
nuclease’’, ‘‘TALEN’’ or ‘‘TAL effector nuclease’’, or ‘‘Cas9’’ in combination with ‘‘pig’’, ‘‘cattle’’, ‘‘sheep’’, or ‘‘goat’’. We hope
that all published work by our dear colleagues are included as of early July 2015; we apologize if yours is unintentionally left out
n.a. not available, SCNT somatic cell nuclear transfer, CPI cytoplasmic injection, HMC hand-made cloning, NHEJ non-homologous
end joining, HDR homology directed repair
* APC Adenomatous polyposis coli, a 1,3GT a1,3-galactosyltransferase (GGTA1), BLG beta-lactoglobulin, CD163 cluster of
differentiation 163, CD1d cluster of differentiation 1d, CMAH CMP-N-acetylneuraminic acid hydroxylase, CSN2 b-casein, DAZL
deleted in azoospermia-Like gene, DJ-1 protein deglycase DJ-1 or Parkinson disease protein 7, GDF8 growth differentiation factor 8
or Myostatin, GHR growth hormone receptor, hLYZ human lysozyme, iGb3S iGb3 synthase, IgM immunoglobulin M, PKD1
polycystin-1, IL2RG interleukin-2 receptor gamma, LDLR low density lipoprotein receptor, lst lysostaphin, MAT1A-
SFTPA1 g introgenic sequence between gene MAT1A and SFTPA1 g, Npc1l1 Niemann-Pick C1-Like 1, PINK1 PTEN-induced
putative kinase 1, PPARc peroxisome proliferator-activated receptorgamma, RAG1/2 recombination activation gene , RELA p65,
SLA-1,2,3 swine leukocyte Ags 1,2, and 3, TYR tyrosinase, PARK2 gene encoding parkin, vWF von Willebrand factor
** ± One allele modified by NHEJ, -/- both alleles modified by NHEJ, =/- mosaicism with up to 5 genotypes but no wt sequence
in a single animal, -/Y X-chromosome gene targeted in male cells, ±/- mosaicism with up to 6 genotypes including wt sequence;
-/Neo, -/in4, -/hLF: one allele modified by NHEJ while the other knockout by a Neo cassette, a 4 bp insertion or a human
lactoferrin expression cassette; ?/lst, ?/hLYZ, ?/SP110: mono-allelic insertion of a transgene, lysostaphin, human lysozyme, or
SP110 nuclear
body protein gene
*** E.T./R/P: total embryos transferred/total recipients/total pregnancies
 Only animals generated by the initial cloning rather than re-cloning are listed
a These are full term foetuses delivered by C-section
b This is accompanied by re-cloning using fibroblasts isolated from an aborted pregnancy
c The donor cells with NHEJ events were mixed with those with HDR alleles for cloning
d Genotyping of the rest of live born piglets were not described
e Only blastocysts were transferred
f The rest of the animals have NHEJ events at least in 2 out of 6 alleles
g -/hLF animals were generated on the – cells background
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sequence changes allow either more precise gene
knockout or targeted integration of various transgenes,
and importantly make allele swapping possible
(Fig. 2).
SCNT has been the primary method to deliver
nuclease mediated genetic changes into livestock. To
date, 33 out of 43 reported successes utilise SCNT and
resulted in 267 edited live animals (Table 1). This
focus on SCNT reflects the lead position this technol-
ogy has had for the last couple of decades in livestock
biology, especially for pigs, since one can apply
nucleases then pre-select editing events in vitro. At
time of writing, SCNT is the only published way to
create livestock with defined changes by HDR
(Fig. 3).
The combination of genome editors and SCNT has
proven to be powerful. It is possible to obtain cells
with bi-allelic modifications in one-step by marker-
free dilution cloning (Tan et al. 2013), or if necessary
FACS sorting (Whyte et al. 2011; Reyes et al. 2014) or
DSB
Deletion
HDRNHEJ
Disruption
Modification
Fig. 2 The utility of double strand breaks generated by genome
editors. A cartoon depiction of the double strand break (DSB)
repair mechanisms. Non homologous end joining (NHEJ) is an
error prone process that re-joins the end of the DSB, often
resulting in small insertions/deletions (blue) and subsequent gene
disruption. Homology dependent repair is a faithful process that
uses a homologous template to repair the DSB. Providing a repair
template, either as a single stranded oligonucleotide or double
stranded DNA, allows specific modifications (green) to be
introduced to the genome. Creation of simultaneous DSBs
flanking a region of the genome can result in deletion of the
intervening sequence (yellow) and repair of the DSBs by either
NHEJ or HDR. (Color figure online)
Fig. 3 A Timeline of genome edited livestock over the past 5 years highlighting specific milestones
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drug selection (Liu et al. 2013; Wu et al. 2015).
Moreover, simultaneous targeting of different genes
has allowed bi-allelic modification of up to three genes
at the same time (Reyes et al. 2014; Li et al. 2015).
Cloning using such cells has resulted in an average
76 % editing rate in live born pigs (Table 2); some of
these animals contain gene inactivating indels result-
ing from NHEJ (Lutz et al. 2013; Whitworth et al.
2014) or ssODN mediated HDR (Tan et al. 2013),
while others have site-specific insertions of transgenes
by HR (Kwon et al. 2013; Wu et al. 2015; Cui et al.
2015).
Production of editor modified animals via SCNT is
hugely successful, but remains tied to the drawbacks
associated with cloning. In the published reports using
editors and SCNT, cloning efficiency has been low,
being only 1.2 % (278/23,216) for pigs and 0.6 % (58/
10,510) for other livestock (Table 2). On average,
production of one edited live pig requires reconstruc-
tion of 130 embryos, which would be challenging
without ready access to abattoir-sourced oocytes. The
cloning efficiency is partly affected by donor cell
quality: prolonged culture and multiple manipulations
of the cells decrease their efficiency as nuclear donors.
Because of this, some studies have required re-cloning
to obtain more founder animals (Hauschild et al.
2011), especially when several genes were targeted
simultaneously (Lutz et al. 2013; Reyes et al. 2014). In
addition, SCNT (even in the absence of nuclease
treatment) is often associated with problems such as
birth defects, abortions and early postnatal death
(Keefer 2015).
To circumvent issues associated with cloning, some
research groups have adopted direct microinjection of
editing reagents to the cytoplasm of zygotes. This
approach has been effective in generating edited
livestock animals using all three designer nucleases
systems in pigs (Lillico et al. 2013; Hai et al. 2014;
Whitworth et al. 2014; Wang et al. 2015), cattle
(Proudfoot et al. 2015) and sheep (Han et al. 2014;
Proudfoot et al. 2015). Although application of CPI
has not been as widely used as SCNT in livestock
genome editing (41 edited animals by CPI vs 267
animals by SCNT (Table 1), its use is gaining
momentum. This shift presumably reflects the sim-
plicity and versatility of CPI over SCNT. While the
Table 2 A summary of edited animals created by SCNT or CPI
Edited/live born Pregnancy rate
A. Success percentages
Pig
SCNT 76 % (179/237) 55.3 % (62/112)
CPI 37 % (29/78) 56.5 % (13/23)
Cattle, sheep and goats
SCNT 81 % (43/53) 27.7 % (267/964)
CPI 8.2 % (4/49) 54.7 % (41/75)
Embryos/recipient Embryos/edited live Live born/pregnancy Edited/pregnancy
B. Ratio of desired outcome across different stages of methodology
Pig
SCNT 207 (23,216/112) 130 (23,216/179) 3.8 (237/62) 2.9 (179/62)
CPI 30 (688/23) 24 (688/29) 6 (78/13) 2.2 (29/13)
Cattle, sheep and goats
SCNT NA 244 (10,510/43) 0.20 (53/267) 0.16 (43/267)
CPI NA 128 (513/4) 1.2 (49/41) 0.10 (4/41)
Only entries with complete records in Table 1 are used for analysis. Pig SCNT data were calculated from 21 entries whereas CPI data
were added up from Lillico et al. (2013), Hai et al. (2014) and Wang et al. (2015). Pig CPI data from Whitworth et al. 2014 were not
included in the analysis because injected embryos were cultured to blastocysts before transfer. For other livestock species, SCNT data
were calculated from five reports whereas CPI data were generated from Han et al. (2014) and Proudfoot et al. (2015)
NA not applicable because in some experiments embryos were transferred shortly after reconstruction or injection while in others
embryos were cultured to blastocysts
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editing efficiency in live-born animals is lower for CPI
(in pigs 37 % for CPI vs 76 % for SCNT), reflecting
the lack of selection that takes place during the in vitro
phase of SCNT, CPI only requires an average of 24
embryos to produce one edited pig, a five-fold
improvement on that currently reported for SCNT
(Table 2). Furthermore, one of the biggest advantages
of CPI is that it can be applied to zygotes from any
desired parental cross, maintaining genetic diversity in
progeny. By contrast, SCNT tends to use genetic
material from a clonal cell population, resulting in
offspring that are genetically identical to the donor
cells and thus requiring subsequent outcrossing to
maintain genetic variation. SCNT, however, enables
selection of a specific mutation prior to production of
animals and potentially enables access to genetic lines
where the correct embryo donors are not readily
available. Thus, both CPI and SCNT offer the
opportunity to utilise the range of editing events that
are produced at a given locus.
Given that there is scope for improving the
proportion of live-born edited animals following
CPI, we anticipate that the numbers of both donor
and recipient animals required per edited offspring
will continue to be reduced. Combined with freedom
from cloning related problems and greater choice in
genetic background, CPI may prove to be the more
compelling method—at least for agricultural applica-
tions. In the meantime there are two areas that require
further investigation; founder mosaicism and efficient
HDR. Mosaicism is commonly observed in edited
animals produced by CPI (Lillico et al. 2013; Han
et al. 2014; Proudfoot et al. 2015), and while this could
be problematic with respect to analysis of phenotype
in the founder generation, our group routinely breed
CPI generated F0 pigs (homozygous, heterozygous or
mosaic) to produce F1 offspring with the desired
genotype (Fig. 4b; unpublished data). Other groups
have confirmed germline transmission from mosaics
by germ cell genotyping (Hai et al. 2014; Wang et al.
2015). Ideally mosaicism following CPI needs to be
reduced; options currently being explored include
maximizing editor concentration while controlling
toxicity and off-target mutations or alternatively
delivering Cas9 as protein rather than mRNA. HDR
mediated editing via CPI has yet to be reported in live-
born animals. However, given the high efficiency of
multiplexing editing events in rodents (Wang et al.
2013; Yang et al. 2013), the recent success by co-
injecting editors and ssODNs into in vitro cultured
bovine embryos (Wei et al. 2015), and data from our
own lab indicating that allele swap animals can be
produced in zygotes (unpublished results), this is
unlikely to prove a significant limitation.
Expanding current trends
Although most of the initial goals in livestock genetic
engineering focused on agriculture (Pursel et al.
1989), the combination of rudimentary (although at
the time innovative) tools, insufficient knowledge of
the genetic consequence of modifying the initial
targets (e.g. growth hormone: Pursel et al. 1989) and
lack of public support lead to a dearth of funding, both
public and commercial, in this area. The result was the
development of applications on the biomedical-
biotechnological interface: animal bioreactors,
Fig. 4 Live genome edited pigs produced by TALEN injection into zygotes. a Founder NHEJ animals born 2012 (Lillico et al. 2013).
b Third generation piglets derived from NHEJ founder animals
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xenotransplantation and, more recently, large animal
models of human disease (Ja¨nne and Alhonen 1998;
Kind and Schnieke 2008; Cooper et al. 2014; Kostic
et al. 2013). Given this spectrum of applications,
impacts of genome editing may be quite variable. For
animal bioreactor projects genome editing technology
can enable refined expression strategies and possibly
be used to augment post-translational effects. While
editing technology could accelerate the development
of even more animal resources for xenotransplanta-
tion, it is perhaps at the interface of these two
applications that genome editing technology may
come to the fore. The remarkable report of chimeric
mice that carried a rat cell derived pancreas (Kobaya-
shi et al. 2010) reignited enthusiasm for the possibility
of animals producing human organs, or at least human
cells. The passage of time since the original report may
have dampened some of the initial optimism, but effort
in this direction continues. Success would be
spectacular.
Within the biomedical arena there is a growing
realisation that small animal models, although deliv-
ering great mechanistic insight into disease in the
model organism, are insufficient as translational tools
for converting this knowledge from bench research to
bedside applications. In many situations we would
benefit from the use of larger animals to model both
the development of disease pathology and the testing
of intervention strategies. Genome editing enables the
mutation of endogenous livestock gene homologues of
known causative or associated human disease loci.
Although there are no projects yet that have fully
exploited this new technology, there are already a
growing number of projects based on the ‘older’
transgenic technologies that have demonstrated that
this belief in large animal disease models is justified
(Wolf et al. 2014; Aigner et al. 2010).
A path to agriculture
Man has pursued the selective breeding of animals for
a long time. Initially our Mesolithic ancestors identi-
fied animals for their ability to breed in captivity based
on aspects of temperament and social structure. Now
engineering enables the targeting introduction of
mutations providing increased genetic variation for
the animal breeder to utilise. Although some agricul-
tural applications of GM have been pursued by the
research community, industry has been shy of engag-
ing with the traditional transgenic technologies. That
reluctance to directly engage with projects involving
livestock appears to have eased with the advent of
genome editing technology.
Historically animal breeding relied on selection by
individual farmers of breeding stock with visibly
desirable traits. Bioinformatic use of genetics allows a
more refined selection process but still relies on
selection of randomly segregating loci that are
predicted to underlie advantageous traits (Daetwyler
et al. 2013; Van Eenennaam et al. 2014; Hill 2014).
Genome editing enables introgression of single
genetic loci in contrast to current breeding regimes.
It enables access to inaccessible variation: variation
that doesn’t exist in a given breeding population
(Lillico et al. 2013), i.e. variation out-with the
breeding gene pool (a currently discussed scenario is
introgression of the polled trait into elite Holstein
cattle). It also offers solutions to non-segregation of
beneficial and undesirable traits due to physical
proximity of the underlying loci in the genome.
Alternatively, genome editing offers a route to elim-
inate deleterious alleles from a gene pool.
Genome editing could also be used to modify
quantitative traits that are affected by many loci
(associated with a number of quantitative trait
nucleotides). In the natural state low levels of recom-
bination will limit the rate favourable alleles will arise
together in selected individuals. This presents chal-
lenges for breeding regimes aiming to improve such a
quantitative trait. Simulations show that even rela-
tively modest multiplexing of genome editing targets
has great potential for increasing the response to
selection in breeding programmes over improvement
by genomic selection alone (Jenko et al. 2015).
Many sectors of the animal agriculture industry,
including those working with pigs, cattle, and chick-
ens are now actively engaged with the technology
through collaborations with the academic community.
There remain the perceived barriers to adoption of
these technologies in animal agriculture including
public opinion and the regulatory environment; but
these factors are in flux. Public opinion is often largely
influenced by a vocal minority of concerned members
of our society, but within society there also exists
support and interest in the potential for genetically
engineered livestock to make a contribution to the
global challenge of food security. This is increasingly
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being reflected by the constructive media portrayal of
this biotechnology. In turn, the political mood is also
changing; for example, the headline in the UK press
early 2015 ‘‘EU regulation on GMOs not ‘fit for
purpose’ say UK MPs’’. Nevertheless, at time of
writing, we still see the regulatory approval for
arguably the world’s lead GM product (the AquAd-
vantage salmon) in the quagmire that occurs when
politics overrides the scientific evidence-based posi-
tion and the approved regulatory process (Van
Eenennaam and Muir 2011).
It is hoped that genome edited livestock (Fahrenk-
rug et al. 2010), with their lack of introduced
transgenes, will find a smoother path through the
regulatory system. In plants the regulatory bodies view
this enzyme-based technology as they would chemical
or radiation induced mutagenesis; the latter two
methods have a long history of unregulated use but
lack the specificity afforded by genome editing tools.
We believe that in this regulatory environments, and
based on the specificity and ‘footprintless’ nature of
genome editing, gene editing animals will successfully
navigate both the political and regulatory landscape.
What is next for genome engineering
Transgenic livestock were first produced in the mid-
1980s and subsequently through the use of HR and
SCNT, gene targeting in large animals has been
possible since the late 1990s (Clark and Whitelaw
2003). Gene editing brings nothing conceptually new
to the table. Rather, this set of tools greatly facilitates
what was already possible with traditional methods,
increasing the rate at which new projects can be
delivered. This is fast becoming reality with an
incredible pace of progress being evident—for those
engaged with the literature there is the real feeling that
as many new lines of engineered large animals have
been produced in the last few years as in the previous
three decades.
Some believe genome editing tools provide the best
imaginable technology for mutating the germline.
Indeed it is hard at the moment to imagine what could
be better. Nevertheless there are remaining challenges.
We need to improve efficiency of editing within a
given population of cells (destined for SCNT) and in
the zygote and overcome mosaicism. In our work with
zygotes we regularly achieve 30 % editing frequency
with delivery of editors—ZFN, TALEN and CRISPR/
Cas9—to the cytoplasm of livestock. We should aspire
to at least[50 % and why not frequencies approach-
ing or even achieving 100 %.
We need to further refine our predictive editor
design algorithms. The scope to expand the repertoire
of editing reagents continues through the development
of Cas9 variants (Kleinstiver et al. 2015; Ran et al.
2015) and meganucleases (Me´noret et al. 2013) is
already materializing with the promise that manymore
will be forthcoming. For real utility in addressing
multi-quantitative nucleotides underlying a quantita-
tive locus we will need the ability to multiplex editing
events. Conceptually this could be challenging, given
the possibility for multiple target sites in a given
genome to undergo inter-site events, resulting in
deletion or other forms of recombination, yet the
production mice with of three consecutively edited
sites has been reported.
For reasons both practical and public perception
based, the concern about off-targets must be
addressed. Off-target effects occur because the editing
complex relies on base-recognition affinity for target-
ing but can cut at a lower frequency at similar non-
target sites (analogous to the star activity exhibited by
restriction endonucleases). Although a much dis-
cussed point, the emerging evidence now suggest that
off-targets may be rare events in mice (Iyer et al.
2015), supporting previous human cell data (Kim et al.
2015). Nevertheless there is probably still room for
improvement, although the debate about what could be
tolerated for a given application remains to be
resolved. To address this aspect a multitude of
strategies are being evaluated. For example, masking
Cas9 with a fusion peptide preventing activity until
cleaved by a small molecule (Davis et al. 2015),
expanding the TALEN RDV repertoire (Miller et al.
2015), dimerisation of the editing enzyme (Wright
et al. 2015; Zetsche et al. 2015), use of nickases which
cause single strand-breaks rather than double-strand
breaks therefore evoking different DNA repair pro-
cesses (Frock et al. 2015) and, further in this vein, the
inhibition of NHEJ (Maruyama et al. 2015; Chu et al.
2015).
Continued development of genome editing tools
will accelerate livestock biotechnology through their
ease of use. Where it took several painfully taxing
years for several groups around the world to produce
alpha-1,3 galactosyltransferase null pigs, this can now
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rapidly and easily be achieved through the use of
genome editors. This ‘catch-up’ phenomenon is not
unique to these tools and reflects all aspects of
technological advance (most obvious in our ability to
sequence genomes). And like other significant tech-
nology leaps, this results is more and greater diversity
in applications. Concerns of off-targets are reducing
and the political landscape increasingly supportive.
Although currently there is a crowded intellectual
property landscape enveloping the genome editors
(e.g. Sherkow 2015), paths through this legal envi-
ronment will resolve with time.We are only at the start
of this wave of advance—the world for livestock
biotechnology is about to get very exciting.
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